Cimaher
Antineoplastic. Monoclonal antibody that joins the epidermic growth factor receptor. Indicated in head and neck cancer, esophagus cancer, pancreatic cancer, glioblastoma.
Therapeutic Area
Oncology
Active Ingredient
Nimotuzumab
Line
Oncology
Pharmaceutical Form
4 10ml ampoules with 50 mg of solution in a 5 mg/ml concentration
